ZNF444 Antibody (PCRP-ZNF444-1E11) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24289IR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # PCRP-ZNF444-1E11
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment (around aa25-105) of human ZNF444 protein
Localization
Nucleus.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for ZNF444 Antibody (PCRP-ZNF444-1E11) [DyLight 755]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ZNF444
Alternate Names
HZF3, MGC126498, zinc finger protein 268, zinc finger protein 3, Zinc finger protein HZF3
Gene Symbol
ZNF444
Additional ZNF444 Products
Product Documents for ZNF444 Antibody (PCRP-ZNF444-1E11) [DyLight 755]
Product Specific Notices for ZNF444 Antibody (PCRP-ZNF444-1E11) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...